Yudai Ishiyama MD, PhD (@yuish_uro) 's Twitter Profile
Yudai Ishiyama MD, PhD

@yuish_uro

フロリダ在住中の泌尿器科医. 専門は泌尿器悪性腫瘍と腎不全. Urologic surgeon in training. @UFJaxurology via Tokyo. GU cancers (kidney/bladder/prostate) and kidney disease. Views my own.

ID: 1471297082283917312

calendar_today16-12-2021 01:52:25

18 Tweet

42 Followers

74 Following

Yudai Ishiyama MD, PhD (@yuish_uro) 's Twitter Profile Photo

健康面やFamily matterを理由にサボっていたら、気づけば最後の投稿がほぼ1ヶ月前… また再開していきます☀️

Kevin Koo (@kvnkoo) 's Twitter Profile Photo

Older urologists and those in private practice are significantly more likely to give extended antibiotics after surgery for noninfected stones, discordant with AUA prophylaxis guidelines. Important insights from Kelly Lehner using #AUACensus data for abx stewardship #WCET25

Older urologists and those in private practice are significantly more likely to give extended antibiotics after surgery for noninfected stones, discordant with AUA prophylaxis guidelines. Important insights from <a href="/KellyLehnerMD/">Kelly Lehner</a> using #AUACensus data for abx stewardship #WCET25
OncoAlert (@oncoalert) 's Twitter Profile Photo

End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive #BladderCancer buff.ly/tXG0flK This study presents international consensus recommendations from the IBCG and GSRGT on standardized outcome measures for evaluating

End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive #BladderCancer

buff.ly/tXG0flK 

This study presents international consensus recommendations from the IBCG and GSRGT on standardized outcome measures for evaluating
NEJM (@nejm) 's Twitter Profile Photo

In patients with localized colorectal cancer and PIK3CA hotspot mutations in exon 9 or 20, daily low-dose aspirin resulted in a significantly lower recurrence rate than placebo. ALASCCA phase 3 trial results: nej.md/4mpKXNp Editorial: An Aspirin a Day for Improved

In patients with localized colorectal cancer and PIK3CA hotspot mutations in exon 9 or 20, daily low-dose aspirin resulted in a significantly lower recurrence rate than placebo. ALASCCA phase 3 trial results: nej.md/4mpKXNp 

Editorial: An Aspirin a Day for Improved